ADMETPred: a high-throughput ADMET prediction platform integrating multi-model algorithms and interpretable substructure identification
Science China Life Sciences · 2026-07 · 69 (7) · 2485-2501
DOI: 10.1007/s11427-025-3166-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science China Life Sciences, online erschienen am 26.03.2026. Verfasst von Chuipu Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Informatics, Department of Computer Science, Shantou University, Shantou, 515000, China. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
The prediction of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties plays a critical role in early-stage drug discovery. While artificial intelligence (AI) has demonstrated transformative potential in revolutionizing this field, existing computational tools remain constrained by limitations in throughput, interpretability, and immobilized modeling frameworks. To address these challenges, we developed ADMETPred, an innovative platform that integrates machine learning and graph neural networks to deliver rapid, accurate, and comprehensive ADMET profiling. Trained on rigorously curated datasets comprising 120,616 compounds, ADMETPred employs 189 models combining LightGBM, XGBoost, Random Forest, and graph attention network to predict 27 drug pharmacokinetic, metabolism, and toxicity endpoints. Compared with current tools, ADMETPred demonstrates superior predictive accuracy by leveraging multi-algorithm synergy, high-throughput batch processing capabilities with parallelized architecture, and customizable workflows for improved prediction flexibility. Notably, the platform integrates an interpretable, attention-driven substructure highlighting module to bridge predictions with actionable structural optimization insights. Case studies spanning post-market drug surveillance, natural product toxicity screening, and lead compound preclinical safety assessment demonstrated alignment with experimental and clinical evidence. In summary, ADMETPred provides a practical resource to enhance early-stage drug development by combining lowered usage barriers with reliable ADMET profiling, freely accessible at http://admetpred.pumc.ai-tcm.cn/ .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biomedical Informatics, Department of Computer Science, Shantou University, Shantou, 515000, China.
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
- Beijing Key Lab of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
- Department of Data Science, Wecomput Technology Co., Ltd. (Guangzhou), Guangzhou, 510535, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. fangjs@gzucm.edu.cn.
- State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. liuailin@imm.ac…
Zitieren
APA
Cai, C., Chen, Z., Wang, Z., Wu, L., Liu, Z., Fang, J., & Liu, A. (2026). ADMETPred: a high-throughput ADMET prediction platform integrating multi-model algorithms and interpretable substructure identification. Science China Life Sciences, 69(7), 2485-2501. https://doi.org/10.1007/s11427-025-3166-8
Vancouver
Cai C, Chen Z, Wang Z, Wu L, Liu Z, Fang J, et al. ADMETPred: a high-throughput ADMET prediction platform integrating multi-model algorithms and interpretable substructure identification. Science China Life Sciences. 2026;69(7):2485-2501. doi:10.1007/s11427-025-3166-8
BibTeX
@article{Cai2026,
author = {Cai, Chuipu and Chen, Zhuang and Wang, Zhe and Wu, Lingyu and Liu, Zhihong and Fang, Jiansong and Liu, Ailin},
title = {ADMETPred: a high-throughput ADMET prediction platform integrating multi-model algorithms and interpretable substructure identification},
journal = {Science China Life Sciences},
year = {2026},
volume = {69},
number = {7},
pages = {2485--2501},
doi = {10.1007/s11427-025-3166-8}
}
EUVIMED